lopinavir has been researched along with Carcinoma, Squamous Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bodini, FC; Cavanna, L; Colombi, D; Michieletti, E; Milanese, G; Morelli, N; Silva, M | 1 |
Kim, JY; Lee, BM; Park, YJ; Yoon, S | 1 |
Batman, G; Hampson, IN; Hampson, L; Oliver, AW; Richard, C; Zehbe, I | 1 |
3 other study(ies) available for lopinavir and Carcinoma, Squamous Cell
Article | Year |
---|---|
COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients.
Topics: Aged; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; Carcinoma, Squamous Cell; Coronavirus Infections; COVID-19; Disease Outbreaks; Drug Therapy, Combination; Esophageal Neoplasms; Fatal Outcome; Humans; Hydroxychloroquine; Italy; Lopinavir; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.
Topics: Antimitotic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Fluphenazine; Furans; HIV Protease Inhibitors; Humans; Ketones; Lopinavir; Mouth Neoplasms; Nelfinavir; Ritonavir; Vincristine | 2019 |
Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells.
Topics: Antiviral Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Endoribonucleases; Female; HIV Protease Inhibitors; Human papillomavirus 16; Humans; Lopinavir; Papillomavirus Infections; Pyrimidinones; Up-Regulation; Uterine Cervical Neoplasms | 2011 |